Girish N. Vyas, Ph.D.
Girish N. Vyas, Ph.D. is the founder of TheraBiol Inc, a biotech start-up in San Francisco, California, launched in July 2012 with the support of QB3 program at UCSF. He served as Professor in the Department of Laboratory Medicine at UCSF School of Medicine in San Francisco, and a Visiting Professor in Departments of Pediatrics, and Pathology and Laboratory Medicine in the David Geffen School of Medicine at UCLA, Los Angeles, California. He was admitted as a Fellow of the Royal College of Pathologists (UK) in 2012.
He was educated in Bombay, India. He attended the Fellowship School, graduated from St. Xavier’s College in 1954, majoring in Medical Microbiology, and joined the Department of Pathology at G.S. Medical College to earn his M.Sc. (1956) and his Ph. D. degree in 1964 from the University of Bombay. He was a postdoctoral fellow (1965-67) at Western Reserve University in Cleveland, Ohio. Since 1967 he has served on the faculty of UCSF School of Medicine. He served as the Director of the Blood Bank at UCSF Medical Center from 1969-88. His research contributions in transfusion safety, IgA deficiency, viral hepatitis B, and transfusion-transmitted HIV have culminated in his current research pursuit on passive-active prophylaxis against population-prevalent HIV-1. He has served on several committees of AABB, ASH, CDC, FDA, NAS-NRC, NIH, UNDP and WHO. He received the Jean Julliard Prize at the 1969 Congress of the International Society of Blood Transfusion in Moscow. In 1973 he worked at the Clinical Research Unit of the Walter and Eliza Hall Institute and the Royal Melbourne Hospital in Australia during his first sabbatical leave. He was awarded a Senior Fulbright Fellowship in 1980 to work at the Pasteur Institute in Paris, France during his second sabbatical leave. His academic achievements were featured in the series on “Pioneers and Pathfinders” published in Transfusion Medicine Reviews (2008). He is currently a Board Member of Geneva-based International Alliance for Biological Standardization (IABS), Chairman of the IABS Publications Committee, and Editor-in-Chief of BIOLOGICALS published by Elsevier. He has edited 12 books and monographs and published 225 original papers on his research in human genetics, virology and immunology relating to Transfusion Medicine.